文献
J-GLOBAL ID:201402274624655812
整理番号:14A0338932
急性骨髄性白血病のシタラビンに基づいた治療への応答を識別するBH3プロファイリング
BH3 Profiling Discriminates Response to Cytarabine-Based Treatment of Acute Myelogenous Leukemia
著者 (13件):
PIERCEALL William E.
(Eutropics Pharmaceuticals, Cambridge, Massachusetts)
,
KORNBLAU Steven M.
(Molecular Hematology and Therapy, Dep. of Stem Cell Transplantation)
,
KORNBLAU Steven M.
(Div. of Cancer Medicine, Dep. of Leukemia)
,
CARLSON Nicole E.
(Eutropics Pharmaceuticals, Cambridge, Massachusetts)
,
HUANG Xuelin
(Dep. of Biostatistics, Univ. of Texas MD Anderson Cancer Center, Houston, Texas)
,
BLAKE Noel
(Eutropics Pharmaceuticals, Cambridge, Massachusetts)
,
LENA Ryan
(Eutropics Pharmaceuticals, Cambridge, Massachusetts)
,
ELASHOFF Michael
(Eutropics Pharmaceuticals, Cambridge, Massachusetts)
,
KONOPLEVA Marina
(Molecular Hematology and Therapy, Dep. of Stem Cell Transplantation)
,
KONOPLEVA Marina
(Div. of Cancer Medicine, Dep. of Leukemia)
,
CARDONE Michael H.
(Eutropics Pharmaceuticals, Cambridge, Massachusetts)
,
ANDREEFF Michael
(Molecular Hematology and Therapy, Dep. of Stem Cell Transplantation)
,
ANDREEFF Michael
(Div. of Cancer Medicine, Dep. of Leukemia)
資料名:
Molecular Cancer Therapeutics
(Molecular Cancer Therapeutics)
巻:
12
号:
12
ページ:
2940-2949
発行年:
2013年12月
JST資料番号:
W1322A
ISSN:
1535-7163
資料種別:
逐次刊行物 (A)
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)